Tenet Healthcare jumps as Q1 profit beats expectations, USPI strength offsets revenue headwinds
Tenet Healthcare shares jumped after reporting Q1 2026 results that beat profit expectations, led by stronger-than-expected Adjusted EBITDA of $1.162 billion and adjusted EPS of $4.82. The company reiterated full-year 2026 Adjusted EBITDA guidance of $4.485–$4.785 billion and highlighted continued USPI growth momentum.
1. What happened
Tenet Healthcare (THC) is higher today after the company posted a stronger-than-expected first-quarter 2026 earnings print. Investors focused on the profitability beat—especially consolidated Adjusted EBITDA of $1.162 billion and adjusted diluted EPS of $4.82—despite some revenue and mix headwinds, signaling that cost execution and outpatient growth are still carrying results. (tradingview.com)
2. Key numbers driving the move
For Q1 2026, Tenet reported net operating revenue of about $5.37 billion and consolidated Adjusted EBITDA of $1.162 billion (about a 21.6% margin), with adjusted EPS of $4.82. The EBITDA figure came in above expectations referenced in company commentary/market recaps, and the earnings beat was reinforced by continued strength in USPI, where management highlighted outperforming its internal first-quarter EBITDA target pace. (markets.chroniclejournal.com)
3. Guidance and outlook signals
Tenet reiterated full-year 2026 consolidated Adjusted EBITDA guidance of $4.485 billion to $4.785 billion, helping the market look through near-term revenue pressure tied to payer mix dynamics. Management also discussed items embedded in the 2026 framework (including non-recurring Conifer-related revenue recognition and headwinds tied to expiring enhanced premium tax credits), which investors are weighing against the company’s operational execution and outpatient growth trajectory. (tradingview.com)
4. Capital allocation and other notable items
Tenet also pointed to ongoing capital returns, including repurchasing 1.35 million shares for $318 million during the quarter, which can add incremental support to per-share earnings power when combined with operating leverage. Separately, the quarter reflected revenue tied to the early contract conclusion linked to the CommonSpirit-related Conifer transaction, a factor investors will adjust for when assessing underlying run-rate performance. (fool.com)